Have you ever wondered about the hidden costs and implications of undermanaging non-biologic implants? In a revealing webinar, we teamed up with our partners at Terso Solutions to spotlight a critical issue: the undermanagement of non-biologic implants and the untapped potential of a comprehensive tissue and implant management program.
The High Cost of Inefficiency
Hospitals invest nearly a third of their supply chain budgets into implants. Yet, inefficiencies in managing these items—ranging from wasteful overstocking to recall risks—pose significant financial and safety risks. The intricate process of tracking and managing implants through their lifecycle requires accurate, real-time data. Traditional, disjointed methods fail to address the sheer volume and complexity, resulting in unused implants, increased waste, and compromised patient safety.
Financial and Patient Safety Implications
The financial repercussions of undermanagement are stark, with hospitals facing losses from expired or misplaced implants and the cascading costs of emergency orders and surgical delays. More critically, the safety risks are profound, given that 95% of recalls involve non-biologics, highlighting an urgent need for swift, accurate tracking and recall management.
Why Extend Managing Tissue to Non-Biologic Implants
More than 700 hospitals have transitioned from siloed data and manual methods to InVita's UDITracker software for tissue management. This shift, initially compliance-driven, revealed unexpected benefits of reduced waste and spend. Considering the high cost and the fact that non-biologic implants account for most recalls, it's both logical and essential to extend management strategies to these critical items.
Overcoming Barriers with Data Integration and Automation
Managing the extensive volume of implants has shifted from daunting to doable. InVita’s robust integrations and innovative features offer advanced capabilities, bringing precision and ease to the process. This data-integrated approach not only safeguards valuable inventory but streamlines operations, ensuring a more efficient, accurate, safe, compliant, and cost-effective solution, minimizing the burden on staff and paving the way for a complete tissue and implant management program.
Partnering for RFID Device Management
The collaboration between InVita and Terso Solutions offers healthcare organizations a data-integrated solution to help ease the pain of inventory management. With RFID Device Management we’re extending boundaries in inventory visibility and control. The ability to identify, monitor, manage and protect high-value inventory has resulted in tangible outcomes, that has led to dramatic reductions in expiration rates, stockouts, and improved compliance, solidifying the value of data-integrated solutions.
Automating Recalls for Improved Patient Safety
Recall management in today’s implant-saturated market demands automation. Traditional methods relying on third-party notification services and cumbersome manual data sorting puts patients at risk due to delayed recall actions. InVita's RecallConnect automates the recall process by integrating with EHRs, the FDA Recall Database, and device manufacturers' databases, allowing staff to identify affected patients and recalled inventory items, shortening response time and issue reconciliation.
Uncovering New Savings with Implant360 Analytics
Utilizing Implant360's item-level analytics, hospitals can optimize inventory and manage implant volumes efficiently to reduce costs by providing a 360o view of performance by department, facility, or enterprise. Real-time tracking of item-level usage enables facilities to anticipate needs, adjust orders, and prevent stockouts and waste. Automated alerts and reports, sorted by risk score and inventory value, prioritizes actions to minimize expiration loss, mitigate risk and avoid unplanned expenses. A strategic analytics approach empowers hospitals to fully realize their inventory investments, optimizing both financial health and operational efficiency.
A Complete Tissue and Implant Management Program
The webinar made a convincing case for adopting an integrated, data-driven approach to tissue and implant management. This strategic move is not just a matter of best practice but a fundamental shift necessary for healthcare organizations to thrive in today’s complex environment.
These insights provide a roadmap for healthcare facilities. By leveraging the solutions that exist, hospitals and health systems can protect their bottom line, alleviate staff workloads, and improve patient outcomes.
The question is no longer if hospitals can afford to manage implants effectively, but rather, can they afford not to?